Kırıkkale University
Kirikkale, Turkey (Türkiye)
Location status: Recruiting
Location contact
Saniye Aydoğan arslan, Assoc. Prof
CONTACT
Serhat Ceylan, pt
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06699381
Patients diagnosed with ischemic or hemorrhagic stroke who applied to Kırıkkale University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation will be included in the study. The aim of our study is to investigate the relationship between spinal alignment, posture and weight transfer symmetry with balance, physical performance and energy expenditure in stroke patients.
Interested in participating?
Request Info18 year–75 year
All sexes
Observational
Kirikkale, Turkey (Türkiye)
Location status: Recruiting
Saniye Aydoğan arslan, Assoc. Prof
CONTACT
Serhat Ceylan, pt
PRINCIPAL_INVESTIGATOR
Patients diagnosed with ischemic or hemorrhagic stroke who applied to Kırıkkale University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation will be included in the study. The number of patients to be included in our study will be determined by power analysis.
Sociodemographic information (Age, Gender, Body Mass Index, Dominant Side) of the individuals included in the study will be recorded.
Information about the stroke (cause of stroke, time elapsed since stroke, side of involvement, neglect after stroke, comorbidities, history of falls in the last six months and 1 year, use of assistive devices, etc.) will be recorded.
When we examine the literature, there are many separate studies on the alignment of the pelvis after stroke, weight transfer symmetry, postural control and energy consumption of individuals with stroke. However, there is a lack of studies on spinal alignment in stroke patients in general. Therefore, the aim of this study was to investigate the relationship between spinal alignment, posture and weight transfer symmetry with balance, physical performance and energy expenditure in stroke patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Spinal Mouse (SM) is an external non-invasive measurement device that evaluates the spinal angle and shape in the frontal and sagittal planes
According to Brunnstrom's stages of recovery, the individual will be identified at which stage
It evaluates the functional capacity of the individual and it provides valuable information regarding all the systems during physical activity, including pulmonary and cardiovascular systems, blood circulation, neuromuscular units, body metabolism, and peripheral circulation
Functional Reach Test (FRT) is a clinical outcome measure and assessment tool for ascertaining dynamic balance in in simple task.
In standing, measures the distance between the length of an outstretched arm in a maximal forward reach, while maintaining a fixed base of support.
This information is correlated with risk of falling A number of factors exert a major influence on this evaluation: Research revealed that movement strategy and reduced spinal flexibility both affect reach distance.
This test measures dynamic balance, functional mobility, and gait. It is commonly used in populations who have or have had multiple sclerosis (MS), Parkinson disease (PD), strokes, spinal cord injury (SCI), or cancer.
The Mini-BESTest was developed in 2010 from the Balance Evaluation Systems Test (BESTest), then revised in 2013 to clarify inconsistencies in scoring. The scoring instructions were different in the published and online versions. The revision clarified that the Mini-BESTest should be scored out of 28 points. Explanations for how to score items 3, 6, and 14 were also given.
The Mini-BESTest consists of 14 items, including 4 of the 6 sections (anticipatory postural adjustments, reactive postural control, sensory orientation, and dynamic gait) from the BESTest.
It's used to asses functional lower limbs strength, transitional movements, balance, and fall risk in older adults.
The Postural Assessment Scale for Stroke (PASS) is an outcome measure specifically designed to assess and monitor postural control after stroke. It was developed in 1999 as an adaptation of the Fugl-Meyer Assessment balance subscale[1]. It contains 12 four-level items of varying difficulty for assessing ability to maintain or change a given lying, sitting or standing posture
It is a form of measurement in which two scales are used to calculate the weight transferred to the intact and stroke limb. The values obtained as a result of the test are calculated with formulas.
Measurement of the craniovertebral angle; the patient is asked to find the most natural position by flexion and extension of the head in the standing position and a photograph is taken with a digital camera from a distance of 1.5 m to the shoulder level of the patient and this process is repeated 3 times. The images obtained are then digitally calculated with the help of an appropriate program.
Time frame: day 1
The SM device is started at the 7th cervical vertebra and advanced to the anal line. During the measurement, the mouse is lowered from the skin surface at a constant speed from top to bottom at the midpoint of the processus spinosus. Individuals are asked to assume the upright, maximal flexion, maximal extension positions in sequence.
The relevant parameters in each position are thoracic curvature angle, lumbar curvature angle, sacrum-hip angle, tilt angle, mobility assessment (from extension to flexion position). The data transferred by the SM device to the computer via Bluetooth is analyzed and the angular deviation between each vertebra is calculated by the SM software as an angle value. The raw data of the wireless and handheld mouse is transferred to the computer via bluetooth and the data is analyzed by the SM software.
Time frame: day 1
A form of measurement in which two scales are used to calculate the weight transferred to the intact and paralyzed limb. The values obtained as a result of the test are calculated with the following formulas. In this index, percentages close to 0 define equal symmetry and good postural control while standing, while higher percentages define asymmetry and poor postural control. Postural Symmetry (%) = Weight on Paralytic Side / Body Weight - 0.5| x 100 Weight Transfer Symmetry = Weight on Intact Side - Weight on Paralytic Side (%) Total Body Weight.
Time frame: day 1
The PASS contains 12 items that measure a person's balance performance in situations of varying difficulty, such as lying, sitting, standing or changing standing position. The scale is administered under two main headings: during posture maintenance and posture change. Sitting without support, standing with support, standing without support, standing on paretic and nonparetic legs are the balance assessments under the heading of maintaining posture. Lateral rotation from supine to paretic and nonparetic side, lateral rotation from supine to sitting, from sitting to supine, from sitting to supine, from sitting to supine, from sitting to standing, from standing to sitting, and picking up a pen on the floor while standing are balance assessments under the heading of posture change. The scale is evaluated between 0-36. The feasibility of the movement is tested between 0-3; "0" is the lowest value; "3" is the highest value
Time frame: day 1
Mini-BEST Test will be used to determine balance level. It consists of 4 sub-parameters including preparatory movement, reactive postural control, sensory orientation, dynamic walking and a total of 14 items. It is a test that is evaluated over a total of 28 points and requires an average of 10-15 minutes. High score indicates high function
Time frame: day 1
It is used to measure both the individual's functional balance and the amount of dynamic reaching. Patients will first be asked to extend their arm straight forward and the distance they reach will be recorded. They will then be asked to reach as far as they can reach forward without lifting their heels off the floor. The maximum value at which he/she can reach and return to his/her original position without losing his/her balance will be measured. Repeating 3 times, these three values will be averaged
Time frame: day 1
The timed stand and walk test (STWT) is used to assess timed performance. In the application, the individual first gets up from the chair, walks 3 meters, then walks back to the same chair and sits down again. The patient's time to complete the test is measured with a stopwatch. Measuring the time taken during this performance is used to determine the functional mobility of the person. Accordingly, completing the task in ≤ 10 seconds indicates that functional mobility is normal, completing the task in 10-20 seconds indicates that mobility is good, the person can walk with or without a device, can go out alone, completing the task in 20-30 seconds indicates that there is a serious problem with mobility and that the person performs mobility using an assistive device.
Time frame: day 1
6 Minute Walk Test (6MWT): Physiological expenditure index (PEI) will be calculated to evaluate the energy expenditure and walking effort of individuals during the test. During the test, individuals will be asked to walk as fast as possible in a 30-meter straight corridor. Individuals will be told that if they feel tired or breathless during the test, they can rest or stop the test. Standard words of encouragement are used during the test. At the end of the test, the 6MWT distance is recorded in meters. Using age and gender, 6MWT expected values and 6MWT distance (% 6MWT) values expressed as a percentage of the expected values (6MWT distance * Body weight (kg)) are calculated. A 6MWT distance of less than 82% indicates a reduced functional capacity
Time frame: day 1
For the test, the individual is asked to sit on a chair with a height of 43.18 (12 inches) cm with the back straight, feet in contact with the floor and arms crossed on the chest. The individual is asked to sit on and stand up from the chair 1 time for a trial. After the trial performance, he/she is instructed to sit on the chair and stand up as quickly as possible and without stopping, and the elapsed time at the end of the fifth repetition is recorded. Validity and reliability studies were conducted in individuals with stroke 20-29 yrs ⇒ 6.0±1.4 sec 30-39 yrs ⇒ 6.1±1.4 sec 40-49 yrs ⇒ 7.6±1.8 sec 50-59 yrs ⇒ 7.7±2.6 sec 60-69 yrs ⇒ 8.4±0.0 sec (male), 12.7±1.8 sec (female) 70-79 yrs ⇒ 11.6±3.4 sec (male), 13.0±4.8 sec (female) 80-89 yrs ⇒ 16.7±4.5 sec (male), 17.2±5.5 sec (female) 90+ yrs ⇒ 19.5±2.3 sec (male), 22.9±9.6 sec (female)
Time frame: day 1
Measurement of the craniovertebral angle; the patient is asked to find the most natural position by flexion and extension of the head in the standing position and a photograph is taken with a digital camera from a distance of 1.5 m to the shoulder level of the patient and this process is repeated 3 times. The images obtained are then digitally calculated with the help of an appropriate program.
Contact information is provided by the study sponsor or research team.
Saniye Arslan, Assoc.Prof.
CONTACT
Serhat Ceylan, PT, MSc.
CONTACT
Kırıkkale University
Other
Investigation Of The Relationship Between Spinal Straightness And Posture And Balance, Physical Performance And Energy Consumption In Individuals With Stroke
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04911738
Brain Diseases, Cardiovascular Diseases
Grenoble, France
View Trial DetailsNCT05378035
Arrhythmias, Cardiac, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT03821129
Brain Diseases, Cardiovascular Abnormalities
Tucson, Arizona, United States
View Trial DetailsNCT06615973
Brain Disease, Brain Diseases
Bethesda, Maryland, United States
View Trial Details